Alertness enhancement

Alertness enhancement" does not refer to a specific molecule or receptor but rather describes the process or interventions aimed at increasing an individual's state of alertness. Alertness itself is regulated by complex neurobiological pathways involving multiple neurotransmitters—such as dopamine, norepinephrine, serotonin, acetylcholine, histamine—and neuromodulators like orexin. Various drugs can enhance alertness by acting on these systems; for example, caffeine increases alertness by blocking adenosine receptors in the brain. However, "alertness enhancement" should not be considered a canonical therapeutic target like an enzyme or receptor—it represents an outcome influenced by many targets rather than being one itself[2][3][4][5]. There may be confusion if "Alertness enhancement" appears in structured drug-target databases; it should be flagged as incorrect because it does not correspond to any single molecular entity suitable for direct pharmacological targeting.

Other names

AlertnessWakefulness enhancementCognitive arousal improvement

Blockade of adenosine receptors (e.g., caffeine)[5]; Inhibition of dopamine reuptake; Enhancement of acetylcholine signaling; Modulation of noradrenergic and serotonergic pathways[2][3][4]